Fundz

MacroGenics

Rockville, Maryland, United States · Biopharma, Biotechnology, Health Care

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. They have a strong emphasis on creating novel and differentiated oncology product candidates.

Key facts

Headquarters
Rockville, Maryland, United States
Employees
350
Industries
Biopharma, Biotechnology, Health Care
Status
Public (MGNX)
Website
macrogenics.com
LinkedIn
Company page

What is happening at MacroGenics

The most recent event Fundz has on record for MacroGenics is dated Nov 13, 2026: On November 13, 2026, MacroGenics, Inc. provided an updated corporate presentation on its website, detailing new clinical program information. This disclosure is categorized under Regulation FD, which emphasizes that .... In the 12 months to Nov 17, 2026 Fundz recorded 9 dated events for MacroGenics: 7 SEC 8-K filings and 2 deals as the target.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise. As of Nov 17, 2026.

Timing is half of it. See who you already know at MacroGenics

Leadership

  • Eric Risser, Chief Executive Officer

Verified email and direct lines for MacroGenics’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

MacroGenics files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

MacroGenics in the news

Companies similar to MacroGenics

  • Tarsus Pharmaceuticals · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
  • TerSera · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
  • CASI Pharmaceuticals · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
  • Jubilant Therapeutics · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
  • Contineum Therapeutics · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics

About MacroGenics: questions and answers

What is happening at MacroGenics?

The most recent event Fundz has on record for MacroGenics is dated Nov 13, 2026: On November 13, 2026, MacroGenics, Inc. provided an updated corporate presentation on its website, detailing new clinical program information. This disclosure is categorized under Regulation FD, which emphasizes that .... In the 12 months to Nov 17, 2026 Fundz recorded 9 dated events for MacroGenics: 7 SEC 8-K filings and 2 deals as the target.

What does MacroGenics do?

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. They have a strong emphasis on creating novel and differentiated oncology product candidates.

Where is MacroGenics headquartered?

MacroGenics is headquartered in Rockville, Maryland, United States.

How many employees does MacroGenics have?

MacroGenics has about 350 employees.

Who leads MacroGenics?

Eric Risser is a Chief Executive Officer at MacroGenics.

Is MacroGenics a public company?

Yes. MacroGenics is publicly traded under the ticker MGNX.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches MacroGenics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.